11/28/23 06:55 | 11/24/23 | HEPA | Health | Drug | Pharmaceutical Preparations | Wijngaard Peter | NJ | D | | P.m | 15 | 3.07 | 0 | 5 | 111 | 10 | D | | | | | | | | | | | | | | |
9/20/23 11:27 | 9/15/23 | HEPA | Health | Drug | Pharmaceutical Preparations | Wijngaard Peter | NJ | D | | P.m | 17 | 5.61 | 0 | 3 | 200 | 5 | D | | | | | | | | | | | | | | |
9/19/23 09:01 | 9/18/23 | HEPA | Health | Drug | Pharmaceutical Preparations | Foster Robert T | NJ | DO | CEO,Dir | P | 9 | 5.60 | 0 | 2 | 3 | 50 | D | | | | | | | | | | | | | | |
2/18/21 16:06 | 2/16/21 | HEPA | Health | Drug | Pharmaceutical Preparations | Wijngaard Peter | NJ | D | | P | 22 | 2.20 | 0 | 10 | 50 | 30 | D | | | | | | | | | | | | | | |
2/18/21 16:05 | 2/18/21 | HEPA | Health | Drug | Pharmaceutical Preparations | Foster Robert T | NJ | DO | CEO,Dir | P | 40 | 2.00 | 0 | 20 | 79 | 45 | D | | | | | | | | | | | | | | |
2/18/21 16:05 | 2/18/21 | HEPA | Health | Drug | Pharmaceutical Preparations | Cavan John T | NJ | O | CFO | P | 20 | 2.00 | 0 | 10 | 208 | 15 | D | | | | | | | | | | | | | | |
12/21/20 09:17 | 12/18/20 | HEPA | Health | Drug | Pharmaceutical Preparations | Wijngaard Peter | NJ | D | | P | 38 | 1.91 | 0 | 20 | New | 20 | D | | | | | | | | | | | | | | |
12/8/20 13:56 | 12/8/20 | HEPA | Health | Drug | Pharmaceutical Preparations | Foster Robert T | NJ | DO | CEO,Dir | P | 39 | 1.58 | 0 | 25 | 999% | 25 | D | | | | | | | | | | | | | | |
12/2/20 18:05 | 12/2/20 | HEPA | Health | Drug | Pharmaceutical Preparations | Brancaccio John P | NJ | D | | P | 11 | 1.53 | 0 | 7 | 999% | 7 | D | | | | | | | | | | | | | | |
12/1/20 19:53 | 12/1/20 | HEPA | Health | Drug | Pharmaceutical Preparations | Jacob Gary S | NJ | D | | P | 20 | 1.66 | 0 | 12 | 999% | 12 | D | | | | | | | | | | | | | | |
11/30/20 16:53 | 11/25/20 | HEPA | Health | Drug | Pharmaceutical Preparations | Cavan John T | NJ | O | CFO | P | 7 | 1.62 | 0 | 5 | 999% | 5 | D | | | | | | | | | | | | | | |
6/22/17 09:00 | 6/20/17 | CTRV | Health | Drug | Pharmaceutical Preparations | Cavan John T | NJ | O | CFO | P | 13 | 0.6500 | 0 | 20 | New | 20 | D | | | | | | | | | | | | | | |
2/18/16 11:10 | 2/18/16 | CTRV | Health | Drug | Pharmaceutical Preparations | Sapirstein James | NJ | DO | CEO | P | 10 | 1.00 | 0 | 10 | 333 | 13 | D | -36 | -75 | -78 | -35 | -33 | 5 | 2 | 14 | 4 | -2 | 14 | -13 | 7 | 56 |
12/1/15 16:05 | 11/30/15 | CTRV | Health | Drug | Pharmaceutical Preparations | Sapirstein James | NJ | DO | CEO | P | 1 | 2.15 | 1 | 1 | 20 | 3 | D | | 67 | -37 | -40 | -3 | 31 | 40 | 15 | -2 | -10 | -37 | -65 | -68 | -15 |
11/24/15 16:15 | 11/23/15 | CTRV | Health | Drug | Pharmaceutical Preparations | Sapirstein James | NJ | DO | CEO | P | 4 | 1.64 | 1 | 3 | New | 3 | D | | 42 | -49 | -54 | -36 | -7 | 15 | 10 | 1 | 26 | -17 | -58 | -59 | 4 |
3/7/14 07:29 | 3/4/14 | CTRV | Health | Drug | Pharmaceutical Preparations | Brancaccio John P | NY | D | | P | 7 | 1.49 | 0 | 4 | 218 | 6 | D | | | | | | -5 | 50 | 20 | 5 | 28 | 25 | 0 | -32 | 167 |